VR Logo

Advanced Enzyme Technologies Ltd.


FMCG | Food Processing

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1989

Chairman: Vasant Rathi

Managing Director: --

Group: --

Listing: NSE: ADVENZYMES, BSE: 540025

Headquarters: Thane, Maharashtra

Website: www.advancedenzymes.com

Key Facts

Market cap: R 3,449.75 Cr

Revenue (TTM): R 444.15 Cr

Earnings (TTM): R 133.88 Cr

Cash: R 206.55 Cr

Total Debt: R 25.55 Cr

Promoters' ownership: 55.45%

Liquidity: High

52 Week range: R 98.10 - 384.75

Face value: R2.00

Shares outstanding: 11,16,78,475

10 Years Aggregate:

  • CFO: 826.16 Cr
  • EBITDA: 1,205.80 Cr
  • Net Profit: 686.84 Cr

Stock Performance

Time Period Advanced Enzyme Technologies S&P BSE FMCG S&P BSE Small Cap
YTD86.74-1.8310.15
1 month5.422.074.10
3 months93.76-1.8017.53
1 Year87.76-6.9513.37
3 Years5.262.89-4.46
5 Years--6.645.66
10 Years--12.063.38
As on 27-Oct-2020
Year Advanced Enzyme Technologies S&P BSE Small Cap S&P BSE FMCG
2019-5.86-6.85-3.58
2018-36.14-23.4110.54
2017-30.0459.6431.54